Gemcitabine and cisplatin in a multimodality treatment for locally advanced non-small cell lung cancer

The role of new cytotoxic agents like gemcitabine has not yet been proven in the neoadjuvant settings. We designed a phase II study to test the feasibility of using gemcitabine and cisplatin before local treatment for stage III non-small cell lung cancer patients. Patients received three cycles of i...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, C H, Tsai, C M, Wang, L S, Lee, Y C, Chang, C J, Lui, L T, Yen, S H, Hsu, C, Cheng, A L, Liu, M Y, Chiang, S C, Chen, Y M, Luh, K T, Huang, M H, Yang, P-C, Perng, R-P
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2002
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375194/
https://www.ncbi.nlm.nih.gov/pubmed/11870504
http://dx.doi.org/10.1038/sj.bjc.6600044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375194/
https://www.ncbi.nlm.nih.gov/pubmed/11870504
http://dx.doi.org/10.1038/sj.bjc.6600044

Ejemplares similares